Plasma endothelin-1 level is a predictor of 10-year mortality in a general population: The tanushimaru study

Circulation Journal

Volumn 76, Issue 12, 2012, Pages 2779-2784

  Yokoi, Kanako ^a   Adachi, Hisashi ^a   Hirai, Yuji ^a   Enomoto, Mika ^a   Fukami, Ako ^a   Ogata, Kinuka ^a   Tsukagawa, Eri ^a   Kasahara, Akiko ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelin; Epidemiology; Mortality; Prospective study

Indexed keywords

ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MALE; NORMAL HUMAN; PROPORTIONAL HAZARDS MODEL; SURVIVAL PREDICTION; SURVIVAL RATE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CONFOUNDING FACTORS (EPIDEMIOLOGY); ENDOTHELIN-1; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84870557718     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0469     Document Type: Article

References (28)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
2. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001.
3. Cadillo C, Kilcoyne CM, Waclawiw M, Cannon RO III, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999; 33: 753-758.
4. Parker JD, Thiessen JJ. Increased endothelin-1 production in patients with chronic heart failure. Am J Physiol Heart Circ Physiol 2004; 286: H1141-H1145.
5. Lerman A, Holmes DR, Bell MR, Garratt KN, Nishimura RA, Burnett JC. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92: 2426-2431.
6. Larivière R, Lebel M. Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol 2003; 81: 607-621.
7. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma en-dothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994; 89: 1573-1579.
8. Van Beneden R, Gurné O, Selvais PL, Ahn SA, Robert AR, Ketelslegers JM, et al. Superiority of big endothelin-1 and endothelin-1 over na-triuretic peptides in predicting survival in severe congestive heart failure: A 7-year follow-up study. J Card Fail 2004; 10: 490-495.
9. Newton DJ, Khan F, McLaren M, Kennedy G, Belch JJ. Endothelin-1 levels predict 3-year survival in patients who have amputation for critical leg ischaemia. Br J Surg 2005; 92: 1377-1381.
10. Spinella F, Rosano L, Di Castro V, Decandia S, Nicotra MR, Natali PG, et al. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1α in human melanoma cells. Cancer Res 2007; 67: 1725-1734.
11. Rosano L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, et al. Endothlin-1 induces tumor proteinase activation and invasive-ness of ovarian carcinoma cells. Cancer Res 2001; 61: 8340-8346.
12. Mai HQ, Zeng ZY, Zhang CQ, Feng KT, Guo X, Mo HY, et al. Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma. Cancer 2006; 106: 1548-1553.
13. Elahi MM, Everson NW. Prognosis of colorectal cancer patients with elevated endothelin-1 concentrations. Asian J Surg 2004; 27: 4-9.
14. Arun C, DeCatris M, Hemingway DM, London NJ, O'Byrne KJ. Endothelin-1 is a novel prognostic factor in non-small cell lung cancer. Int J Biol Markers 2004; 19: 262-267.
15. Hirai Y, Geleijnse JM, Adachi H, Imaizumi T, Kromhout D. Systolic blood pressure predicts cardiovascular mortality in a farming but not in a fshing community: A 40-year follow-up of the Japanese cohorts of the Seven Countries Study. Circ J 2011; 75: 1890-1896.
16. Hino A, Adachi H, Toyomasu K, Yoshida N, Enomoto M, Hiratsuka A, et al. Very long chain N-3 fatty acids intake and carotid atherosclerosis: An epidemiological study evaluated by ultrasonography. Atherosclerosis 2004; 176: 145-149.
17. De Bacquer D, De Backer G, Kornitzer M. Prevalence of ECG fnd-ings in large population based samples of men and women. Heart 2000; 84: 625-633.
18. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. and Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
19. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of im-munoreactive endothelin in human plasma. FEBS Lett 1989; 245: 164-166.
20. World Health Organization. International Statistical Classifcation of Diseases and Related Health Problems. 10th Revision. Geneva: WHO, 2003.
21. Hirai Y, Adachi H, Fujiura Y, Hiratsuka A, Enomoto M, Imaizumi T. Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: An epidemiological study. J Hyper-tens 2004; 22: 713-718.
22. Health and Welfare Statistics Association. Analysis of cause of death. J Health Welf Stat 2010/2011; 57: 70-71 (in Japanese).
23. Fujiura Y, Adachi H, Tsuruta M, Jacobs DR, Hirai Y, Imaizumi T. Heart rate and mortality in a Japanese general population: An 18-year follow-up study. J Clin Epidemiol 2001; 54: 495-500.
24. Konishi M, Iso H, Komachi Y, Iida M, Shimamoto T, Jacobs DR, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries: The Akita Pathology Study. Stroke 1993; 24: 954-964.
25. Blackburn H, Jacobs DR. The ongoing natural experiment of cardiovascular disease in Japan. Circulation 1989; 79: 718-720.
26. Huang H, Zhang P, Wang Z, Tang F, Jiang Z. Activation of endothe-lin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease. Circ J 2011; 75: 1463-1471.
27. Piechota M, Banach M, Jacon A, Rysz J. Natriuretic peptides in cardiovascular diseases. Cell Mol Biol Lett 2008; 13: 155-181.
28. Hillier C, Petrie MC, Love MP, Johnston F, MacLean MR, McMurray JJV. Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: Evidence for a receptor-specifc functional interaction in patients with heart failure. Clin Sci 2001; 101: 45-51.